Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/18825
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
- IOC - Artigos de Periódicos [12969]
Metadata
Show full item record
IMPROVING INFLUENZA VACCINE VIRUS SELECTION: REPORT OF A WHO INFORMAL CONSULTATION HELD AT WHO HEADQUARTERS, GENEVA, SWITZERLAND, 14-16 JUNE 2010
Author
Baylor, Norman
Cobey, Sarah
Cox, Nancy J.
Daves, Sharon
Edwards, Steven
Ferguson, Neil
Grohmann, Gary
Hay, Alan
Katz, Jacqueline
Kullabutr, Kornnika
Lambert, Linda
Levandowski, Roland
Mishra, A. C.
Monto, Arnold
Siqueira, Marilda Agudo Mendonça Teixeira de
Tashiro, Masato
Waddell, Anthony L.
Wairagkar, Niteen
Wood, John
Zambon, Maria
Zhang, Wenqing
WHO Writing Group William K. Ampofo
Cobey, Sarah
Cox, Nancy J.
Daves, Sharon
Edwards, Steven
Ferguson, Neil
Grohmann, Gary
Hay, Alan
Katz, Jacqueline
Kullabutr, Kornnika
Lambert, Linda
Levandowski, Roland
Mishra, A. C.
Monto, Arnold
Siqueira, Marilda Agudo Mendonça Teixeira de
Tashiro, Masato
Waddell, Anthony L.
Wairagkar, Niteen
Wood, John
Zambon, Maria
Zhang, Wenqing
WHO Writing Group William K. Ampofo
Affilliation
Food and Drug Administration. Rockville, MA, USA.
Harvard School of Public Health. Boston, MA, USA.
Centers for Disease Control and Prevention (CDC). Atlanta, GA, USA.
NAMRU-3. Cairo, Egypt.
Network of Expertise on Animal Influenzas (OFFLU) Steering Committee. Hereford, UK.
Imperial College School of Medicine at St Mary’s. London, UK.
Therapeutic Goods Administration Laboratories. Symonston, Australia.
National Institute for Medical Research. London, UK.
Centers for Disease Control and Prevention (CDC). Atlanta, GA, USA.
Ministry of Public Health. Nonthaburi. Thailand.
National Institutes of Health. Bethesda, MD, USA.
Freelancer. Bethesda, MD, USA.
National Influenza Centre. Pune, India.
University of Michigan School of Public Health. AnnArbor, MI, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
WHO Collaborating Centre for Reference and Research on Influenza. Tokyo, Japan.
Freelancer. Stanley, UK.
World Health Organization(WHO). Geneva, Switzerland.
National Institute for Biological Standards and Control(NIBSC). PottersBar, UK.
Health Protection Agency. London, UK.
World Health Organization(WHO). Geneva, Switzerland.
National Influenza Centre. Accra, Ghana.
Harvard School of Public Health. Boston, MA, USA.
Centers for Disease Control and Prevention (CDC). Atlanta, GA, USA.
NAMRU-3. Cairo, Egypt.
Network of Expertise on Animal Influenzas (OFFLU) Steering Committee. Hereford, UK.
Imperial College School of Medicine at St Mary’s. London, UK.
Therapeutic Goods Administration Laboratories. Symonston, Australia.
National Institute for Medical Research. London, UK.
Centers for Disease Control and Prevention (CDC). Atlanta, GA, USA.
Ministry of Public Health. Nonthaburi. Thailand.
National Institutes of Health. Bethesda, MD, USA.
Freelancer. Bethesda, MD, USA.
National Influenza Centre. Pune, India.
University of Michigan School of Public Health. AnnArbor, MI, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
WHO Collaborating Centre for Reference and Research on Influenza. Tokyo, Japan.
Freelancer. Stanley, UK.
World Health Organization(WHO). Geneva, Switzerland.
National Institute for Biological Standards and Control(NIBSC). PottersBar, UK.
Health Protection Agency. London, UK.
World Health Organization(WHO). Geneva, Switzerland.
National Influenza Centre. Accra, Ghana.
Abstract
This article provides a summary of the findings presented at
a WHO informal consultation on improving influenza
vaccine virus selection held at WHO headquarters, Geneva,
Switzerland, 14–16 June 2010.
Share